Similar articles for PMID: 8271059

Year	Number of Results
1986	8
1987	5
1988	4
1989	25
1990	19
1991	26
1992	16
1993	22
1994	22
1995	22
1996	18
1997	18
1998	8
1999	9
2000	7
2001	3
2002	7
2003	7
2004	5
2005	3
2006	4
2007	1
2008	4
2009	4
2010	2
2011	6
2012	4
2013	2
2014	3
2015	4
2016	8
2017	9
2018	4
2019	2
2020	6
2021	2
2022	1
2023	0

1

Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.

Hoshi H, Ohnishi T, Jinnouchi S, Futami S, Nagamachi S, Kodama T, Watanabe K, Ueda T, Wakisaka S. Hoshi H, et al. J Nucl Med. 1994 Jan;35(1):44-50. J Nucl Med. 1994. PMID: 8271059 Free article.

2

Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study.

Saito N, Nakagawara J, Nakamura H, Teramoto A. Saito N, et al. Ann Nucl Med. 2004 Jun;18(4):323-31. doi: 10.1007/BF02984471. Ann Nucl Med. 2004. PMID: 15359926 Clinical Trial.

3

Split dose iodine-123-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention.

Hashikawa K, Matsumoto M, Moriwaki H, Oku N, Okazaki Y, Uehara T, Handa N, Kusuoka H, Kamada T, Nishimura T. Hashikawa K, et al. J Nucl Med. 1994 Jul;35(7):1226-33. J Nucl Med. 1994. PMID: 8014687 Free article.

4

Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.

Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Fukuchi K, Hori M, Nishimura T. Moriwaki H, et al. J Nucl Med. 1998 Aug;39(8):1348-53. J Nucl Med. 1998. PMID: 9708504 Free article.

5

[Regional cerebral blood flow in moyamoya disease using 123-I IMP-SPECT--follow up study before and after therapy].

Konishi T, Naganuma Y, Hongo K, Murakami M, Yamatani M, Okada T, Takaku A. Konishi T, et al. No To Hattatsu. 1991 Sep;23(5):446-52. No To Hattatsu. 1991. PMID: 1931161 Japanese.

6

Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography.

Honda M, Ezaki Y, Kitagawa N, Tsutsumi K, Ogawa Y, Nagata I. Honda M, et al. Surg Neurol. 2006 Aug;66(2):155-9; discussion 159. doi: 10.1016/j.surneu.2005.08.022. Surg Neurol. 2006. PMID: 16876609

7

Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.

Ogasawara K, Ito H, Sasoh M, Okuguchi T, Kobayashi M, Yukawa H, Terasaki K, Ogawa A. Ogasawara K, et al. J Nucl Med. 2003 Apr;44(4):520-5. J Nucl Med. 2003. PMID: 12679394 Free article. Clinical Trial.

8

Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.

Ohnishi T, Yano T, Nakano S, Jinnouchi S, Nagamachi S, Flores LI, Nakahara H, Watanabe K. Ohnishi T, et al. J Nucl Med. 1997 Sep;38(9):1463-7. J Nucl Med. 1997. PMID: 9293809 Free article.

9

[Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].

Makino K, Masuda Y, Gotoh S. Makino K, et al. Kaku Igaku. 1996 May;33(5):551-5. Kaku Igaku. 1996. PMID: 8699624 Japanese.

10

Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine.

Nishizawa S, Yonekura Y, Tanaka F, Fujita T, Tsuchimochi S, Ishizu K, Okazawa H, Tamaki N, Konishi J. Nishizawa S, et al. J Nucl Med. 1995 Jul;36(7):1339-45. J Nucl Med. 1995. PMID: 7790965 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed